HEART-LUNG AND LUNG TRANSPLANTATION FOR CYSTIC-FIBROSIS - WORLD EXPERIENCE

被引:11
作者
TAMM, M [1 ]
HIGENBOTTAM, T [1 ]
机构
[1] PAPWORTH HOSP,DEPT RESP PHYSIOL,CAMBRIDGE CB3 8RE,ENGLAND
关键词
D O I
10.1055/s-2007-1006386
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Heart-lung or bilateral lung transplantation is an option for CF patients with end-stage lung disease, which is associated with poor survival. The most important early complication is bacterial infection with Pseudomonas, usually from the recipient's own airways. Lung function and life quality improves markedly after transplantation. Long-term survival is mainly influenced by the occurrence of OB as major late complication. This complication is usually linked to frequent early rejection. Five-year survival reaches more than 50% in some centers and patients without OB have a good life quality and normal lung function.
引用
收藏
页码:414 / 425
页数:12
相关论文
共 85 条
[1]   RECOMBINANT HUMAN DNASE INHALATION IN NORMAL SUBJECTS AND PATIENTS WITH CYSTIC-FIBROSIS - A PHASE-1 STUDY [J].
AITKEN, ML ;
BURKE, W ;
MCDONALD, G ;
SHAK, S ;
MONTGOMERY, AB ;
SMITH, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (14) :1947-1951
[2]   FAILURE OF PROPHYLACTIC GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE IN RECIPIENTS OF LUNG TRANSPLANTS [J].
BAILEY, TC ;
TRULOCK, EP ;
ETTINGER, NA ;
STORCH, GA ;
COOPER, JD ;
POWDERLY, WG .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :548-552
[3]  
BISSON A, 1992, J THORAC CARDIOV SUR, V103, P40
[4]  
BOREL JF, 1977, IMMUNOLOGY, V32, P1017
[5]   INFECTIOUS COMPLICATIONS IN HEART-LUNG TRANSPLANT RECIPIENTS [J].
BROOKS, RG ;
HOFFLIN, JM ;
JAMIESON, SW ;
STINSON, EB ;
REMINGTON, JS .
AMERICAN JOURNAL OF MEDICINE, 1985, 79 (04) :412-422
[6]   POST-TRANSPLANT OBLITERATIVE BRONCHIOLITIS AND OTHER LATE LUNG SEQUELAE IN HUMAN HEART-LUNG TRANSPLANTATION [J].
BURKE, CM ;
THEODORE, J ;
DAWKINS, KD ;
YOUSEM, SA ;
BLANK, N ;
BILLINGHAM, ME ;
VANKESSEL, A ;
JAMIESON, SW ;
OYER, PE ;
BALDWIN, JC ;
STINSON, EB ;
SHUMWAY, NE ;
ROBIN, ED .
CHEST, 1984, 86 (06) :824-829
[7]  
BURKE CM, 1986, LANCET, V1, P517
[8]  
CAGLE PT, 1989, MODERN PATHOL, V2, P85
[9]  
CAINE N, 1991, TRANSPLANT P, V23, P1203
[10]  
CIULLI F, 1993, TRANSPLANT P, V25, P1155